|
1
|
Baowen Q, Yulin Z, Xin W, Wenjing X, Hao
Z, Zhizhi C, Xingmei D, Xia Z, Yuquan W and Lijuan C: A further
investigation concerning correlation between anti-fibrotic effect
of liposomal quercetin and inflammatory cytokines in pulmonary
fibrosis. Eur J Pharmacol. 642:134–139. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Boots AW, Haenen GR and Bast A: Health
effects of quercetin: From antioxidant to nutraceutical. Eur J
Pharmacol. 585:325–337. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Qu L, Liang X, Gu B and Liu W: Quercetin
alleviates high glucose-induced Schwann cell damage by autophagy.
Neural Regen Res. 9:1195–1203. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim H, Moon JY, Ahn KS and Cho SK:
Quercetin induces mitochondrial mediated apoptosis and protective
autophagy in human glioblastoma U373MG cells. Oxid Med Cell Longev.
2013:5964962013.
|
|
5
|
Wei L, Liu JJ, Cao J, Du NC, Ji LN and
Yang XL: Role of autophagy in quercetin-induced apoptosis in human
bladder carcinoma BIU-87 cells. Zhonghua Zhong Liu Za Zhi.
34:414–418. 2012.In Chinese. PubMed/NCBI
|
|
6
|
Wei YQ, Zhao X, Kariya Y, Fukata H,
Teshigawara K and Uchida A: Induction of apoptosis by quercetin:
Involvement of heat shock protein. Cancer Res. 54:4952–4957.
1994.PubMed/NCBI
|
|
7
|
Murakami A, Ashida H and Terao J:
Multitargeted cancer prevention by quercetin. Cancer Lett.
269:315–325. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Steller H: Mechanisms and genes of
cellular suicide. Science. 267:1445–1449. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hickman JA: Apoptosis induced by
anticancer drugs. Cancer Metastasis Rev. 11:121–139. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang JY: Apoptosis-based anticancer
drugs. Nat Rev Drug Discov. 1:101–102. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
MacFarlane M: TRAIL-induced signalling and
apoptosis. Toxicol Lett. 139:89–97. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang CW and Klionsky DJ: The molecular
mechanism of autophagy. Mol Med. 9:65–76. 2003.PubMed/NCBI
|
|
13
|
Chen N and Karantza V: Autophagy as a
therapeutic target in cancer. Cancer Biol Ther. 11:157–168. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cuervo AM: Autophagy: In sickness and in
health. Trends Cell Biol. 14:70–77. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Seglen PO, Berg TO, Blankson H, Fengsrud
M, Holen I and Strømhaug PE: Structural aspects of autophagy. Adv
Exp Med Biol. 389:103–111. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mortimore GE, Miotto G, Venerando R and
Kadowaki M: Autophagy. Subcell Biochem. 27:93–135. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cuervo AM: Autophagy: Many paths to the
same end. Mol Cell Biochem. 263:55–72. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu B, Bao JK, Yang JM and Cheng Y:
Targeting autophagic pathways for cancer drug discovery. Chin J
Cancer. 32:113–120. 2013. View Article : Google Scholar :
|
|
19
|
Klionsky DJ: Autophagy: From phenomenology
to molecular understanding in less than a decade. Nat Rev Mol Cell
Biol. 8:931–937. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rubinsztein DC, Cuervo AM, Ravikumar B,
Sarkar S, Korolchuk V, Kaushik S and Klionsky DJ: In search of an
‘autophagomometer’. Autophagy. 5:585–589. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sahani MH, Itakura E and Mizushima N:
Expression of the autophagy substrate SQSTM1/p62 is restored during
prolonged starvation depending on transcriptional upregulation and
autophagy-derived amino acids. Autophagy. 10:431–441. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Myeku N and Figueiredo-Pereira ME:
Dynamics of the degradation of ubiquitinated proteins by
proteasomes and autophagy: Association with sequestosome 1/p62. J
Biol Chem. 286:22426–22440. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bartlett BJ, Isakson P, Lewerenz J,
Sanchez H, Kotzebue RW, Cumming RC, Harris GL, Nezis IP, Schubert
DR, Simonsen A, et al: p62, Ref(2)P and ubiquitinated proteins are
conserved markers of neuronal aging, aggregate formation and
progressive autophagic defects. Autophagy. 7:572–583. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Klionsky DJ, Abdalla FC, Abeliovich H,
Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M,
Agostinis P, Aguirre-Ghiso JA, et al: Guidelines for the use and
interpretation of assays for monitoring autophagy. Autophagy.
8:445–544. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu B, Cheng Y, Liu Q, Bao JK and Yang JM:
Autophagic pathways as new targets for cancer drug development.
Acta Pharmacol Sin. 31:1154–1164. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiang L, Hao JL, Jin ML, Zhang YG and Wei
P: Effect of embelin on TRAIL receptor 2 mAb-induced apoptosis of
TRAIL-resistant A549 non-small cell lung cancer cells. Asian Pac J
Cancer Prev. 14:6115–6120. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chaudhari AA, Seol JW, Lee YJ, Seol DW and
Park SY: Hypoxia protects articular chondrocytes from
thapsigargin-induced apoptosis. Biochem Biophys Res Commun.
381:513–517. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Seo JS, Moon MH, Jeong JK, Seol JW, Lee
YJ, Park BH and Park SY: SIRT1, a histone deacetylase, regulates
prion protein-induced neuronal cell death. Neurobiol Aging.
33:1110–1120. 2012. View Article : Google Scholar
|
|
29
|
Agarwal E, Brattain MG and Chowdhury S:
Cell survival and metastasis regulation by Akt signaling in
colorectal cancer. Cell Signal. 25:1711–1719. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Degterev A, Boyce M and Yuan J: A decade
of caspases. Oncogene. 22:8543–8567. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kroemer G and Jäättelä M: Lysosomes and
autophagy in cell death control. Nat Rev Cancer. 5:886–897. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Boya P, González-Polo RA, Casares N,
Perfettini JL, Dessen P, Larochette N, Métivier D, Meley D,
Souquere S, Yoshimori T, et al: Inhibition of macroautophagy
triggers apoptosis. Mol Cell Biol. 25:1025–1040. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Matsumoto G, Wada K, Okuno M, Kurosawa M
and Nukina N: Serine 403 phosphorylation of p62/SQSTM1 regulates
selective autophagic clearance of ubiquitinated proteins. Mol Cell.
44:279–289. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jeong JH, An JY, Kwon YT, Rhee JG and Lee
YJ: Effects of low dose quercetin: Cancer cell-specific inhibition
of cell cycle progression. J Cell Biochem. 106:73–82. 2009.
View Article : Google Scholar :
|
|
35
|
Pattingre S, Tassa A, Qu X, Garuti R,
Liang XH, Mizushima N, Packer M, Schneider MD and Levine B: Bcl-2
antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell.
122:927–939. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang Z and Klionsky DJ: An overview of the
molecular mechanism of autophagy. Curr Top Microbiol Immunol.
335:1–32. 2009.PubMed/NCBI
|
|
37
|
White E and DiPaola RS: The double-edged
sword of autophagy modulation in cancer. Clin Cancer Res.
15:5308–5316. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang K, Liu R, Li J, Mao J, Lei Y, Wu J,
Zeng J, Zhang T, Wu H, Chen L, et al: Quercetin induces protective
autophagy in gastric cancer cells: Involvement of Akt-mTOR- and
hypoxia-induced factor 1α-mediated signaling. Autophagy. 7:966–978.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Singh K, Sharma A, Mir MC, Drazba JA,
Heston WD, Magi-Galluzzi C, Hansel D, Rubin BP, Klein EA and
Almasan A: Autophagic flux determines cell death and survival in
response to Apo2L/TRAIL (dulanermin). Mol Cancer. 13:702014.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Park KJ, Lee SH, Kim TI, Lee HW, Lee CH,
Kim EH, Jang JY, Choi KS, Kwon MH and Kim YS: A human scFv antibody
against TRAIL receptor 2 induces autophagic cell death in both
TRAIL-sensitive and TRAIL-resistant cancer cells. Cancer Res.
67:7327–7334. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shankar E, Sivaprasad U and Basu A:
Protein kinase C epsilon confers resistance of MCF-7 cells to TRAIL
by Akt-dependent activation of Hdm2 and downregulation of p53.
Oncogene. 27:3957–3966. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zauli G, Sancilio S, Cataldi A, Sabatini
N, Bosco D and Di Pietro R: PI-3K/Akt and NF-kappaB/IkappaBalpha
pathways are activated in Jurkat T cells in response to TRAIL
treatment. J Cell Physiol. 202:900–911. 2005. View Article : Google Scholar
|
|
43
|
Fresno Vara JA, Casado E, de Castro J,
Cejas P, Belda-Iniesta C and González-Barón M: PI3K/Akt signalling
pathway and cancer. Cancer Treat Rev. 30:193–204. 2004. View Article : Google Scholar : PubMed/NCBI
|
